Go West to go East
This article was originally published in Scrip
The acquisition that went West to go East. That's Astex, an acquisition announced 5 September for which Japanese pharmaceutical company Otsuka will pay $885m. But Astex's journey has been a long one, and although $885m sounds like a lot of money, it has been a long time in the accruing. Astex was a case of "start-up, work-up, sell-up". Life and the life sciences are much more complicated than that.
You may also be interested in...
Charting the executive gender mix across 384 companies from mid-2014 to mid-2019 demonstrates that C-suite gender balance in pharma is moving towards a point that more closely reflects its total workforce, but that progress has been slow and that there is a long road to travel before the transformation is complete.
With gender diversity only slowly increasing in biopharma c-suites, Scrip spoke to executives from five companies about the importance of change.
In a flat month, the market value of big pharma changed little overall. But the balance of power in immuno-oncology did shift significantly.